Table 2.
Syphilis serological tests in HIV-positive and HIV-negative individuals at St Paul's Hospital, 2010
| HIV positive |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ART users |
ART naïve |
Total |
HIV negative |
|||||||
| Syphilis test | Total tested | Number (%) of positive | Tested | +ve (%) | Tested | +ve (%) | Tested | +ve (%) | Tested | +ve (%) |
| RPR | 530 | 85 (16) | 188 | 36 (19.1) | 118 | 19 (5.6) | 306 | 55 (18) | 224 | 30 (13.4) |
| TPHA | 85 | 33 (38.8) | 36 | 21 (58.3) | 19 | 9 (47.4) | 55 | 30 (54.5) | 30 | 3 (10) |
| Syphilis seropositivity | 530 | 33 (6.2) | 188 | 21 (11.2) | 118 | 9 (7.6) | 306 | 30 (9.8) | 224 | 3 (1.3) |
ART, antiretroviral therapy; RPR, rapid plasma reagin; TPHA, Treponema pallidum haemagglutination; +ve, positive.